CD8A and neoplasm: Spleen cells were collected two weeks after the second tumor cell challenge and tested for the presence of splenic antigen-specific CD8+ T cells (Fig. 7G), effector and central memory CD8+ T cells (Fig. 7H-I), and memory precursors (MPEC) and short-lived (SLEC) effector cells (Fig. 7J-K).